Janssen presents five year data of STELARA in treatment of Crohn’s Disease
Over half of the patients with moderately to severely active CD who were randomised to subcutaneous ustekinumab every eight weeks…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Janssen Pharma
US FDA approves SPRAVATO, antidepressant medication from J&J
The drug indicated to treat adults with major depressive disorder and acute suicidal ideation or behaviour reportedly begins…